The Safety and Effectiveness of Latuda® Post-marketing Surveillance in the Treatment of Chinese Schizophrenia Patients

NCT04432688 · clinicaltrials.gov ↗

COMPLETED

Status

3192

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Lurasidone HCl

Sponsor

Sumitomo Pharma (Suzhou) Co., Ltd.